secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001641172-25-017479
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel implements 1-for-15 reverse stock split effective July 7, 2025
-----------------------------------------------------------------------

- Reverse split at 1:15 ratio, effective July 7, 2025; trading begins split-adjusted that day.
- Pre-split shares outstanding: 23,759,475; post-split: approx. 1,583,965 shares.
- Split approved by board and stockholders; aims to meet Nasdaq minimum bid price requirement.
- No fractional shares; rounding up or down to the nearest whole share.
- New CUSIP 23254L876; ticker remains CYCC on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225017479/0001641172-25-017479-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225017479/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017479

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer